Evidence-Based Benefits
- BPH symptom relief — a landmark 1995 Lancet RCT (n=200) found 20mg TID beta-sitosterol significantly improved IPSS scores, urinary flow rate (+35%), and post-void residual volume vs placebo over 6 months
- Cholesterol reduction — plant sterols including beta-sitosterol reduce LDL cholesterol by 6-15% by competing with dietary cholesterol for intestinal absorption, earning an FDA health claim
- Prostate inflammation — in vitro and animal studies show beta-sitosterol inhibits 5-alpha-reductase and reduces prostaglandin synthesis in prostate tissue
- Immune modulation — a 2003 study found beta-sitosterol enhanced natural killer cell activity and T-cell proliferation at physiological concentrations